Trying to get a library card for a book that hasn’t been written yet, in a building that doesn’t believe in paper

The cannabis industry is a massive marketplace operating in a legal paradox. While most states have legalized some form of cannabis, federal law is still catching up. Because federal trademark registration requires “lawful use in commerce,” the USPTO remains a high hurdle for any brand containing THC or CBD.

As of early 2026, the landscape has shifted again with the rescheduling of cannabis and new updates to the Farm Bill. Understanding where the federal line is drawn is the only way to build a brand that actually has legal protection.

The Controlled Substances Act (CSA) and Rescheduling

Historically, cannabis was a Schedule I substance, making it impossible to register a trademark for anything other than “ancillary” goods like t-shirts or rolling papers. However, with the recent executive order moving cannabis to Schedule III, the door is beginning to crack open.

Rescheduling does not mean full legalization, but it does mean that cannabis is no longer in the same category as heroin. While this change opens up research and banking, the USPTO still requires proof that the specific product you are selling is legal under federal law. For most “plant-touching” businesses, this still means that a federal trademark for the actual flower or THC-infused products is currently out of reach.

The Hemp Loophole and the 2026 Extension Act

Since 2018, “hemp” (cannabis with less than 0.3% Delta-9 THC) has been federally legal. This created a massive market for CBD and “intoxicating hemp” products like Delta-8. However, Congress has recently moved to close this loophole.

The 2026 Extension Act has tightened the definition of hemp. New federal limits now target the total milligram count of all THC variants, not just Delta-9. This means many products that were once “Farm Bill compliant” are now being recategorized as controlled substances. If your product falls into this new restricted category, your trademark application will be refused on the grounds of unlawful use.

The FDA Blockade: Ingestibles vs. Topicals

Even if your product meets the 0.3% THC hemp limit, you still have to clear the Food and Drug Administration (FDA). The FDA currently maintains that CBD is an active ingredient in a prescription drug (Epidiolex). Because of this, they prohibit adding CBD to:

• Foods and beverages
• Dietary supplements
• Pet treats

The USPTO follows the FDA’s lead. If you apply for a trademark for “CBD-infused coffee” or “Hemp gummies,” you will receive a refusal because these products cannot be sold legally in interstate commerce according to the FDA.

The “Safe Zone” remains topical products. Cosmetics, lotions, and balms containing hemp-derived CBD are generally registrable because the FDA does not have the same strict prohibitions against CBD in topicals as it does for ingestibles.

State Trademarks and Ancillary Protection

Because federal protection is so limited, cannabis brands must use a “patchwork” strategy. This involves filing for state-level trademarks in every state where your products are legal. While these don’t offer national protection, they provide a legal footprint in your specific markets.

Additionally, we often file federal trademarks for “ancillary” goods. If you sell cannabis but also have a line of apparel, a podcast about the industry, or branded lighters, we can register those. While this doesn’t protect the cannabis itself, it protects the brand name and prevents others from using your logo in the marketplace.

Plain English Explanation

Trademarks for cannabis are complicated because the federal government and the states don’t agree on what’s legal. Even if you have a license to sell in your state, the federal trademark office will say “no” if your product contains THC or if you’re putting CBD in food. To protect your brand, you have to be strategic—you trademark the things you can (like lotions or merch) at the federal level and use state-specific trademarks for the actual cannabis products.

The TL; DR Summary

Federal trademark registration for cannabis is limited because the USPTO requires products to be legal under federal law, regardless of state legalization. Hemp-derived products with less than 0.3% THC are generally registrable, provided they are not food or supplements. Rescheduling cannabis to Schedule III has improved the legal climate but has not yet opened the door for THC product trademarks. Ingestible CBD products (edibles/drinks) are currently refused by the USPTO due to FDA restrictions.

Key Takeaways

• The 2026 Extension Act has narrowed the definition of legal hemp, making “intoxicating hemp” products harder to trademark.
• Topical CBD products like lotions and cosmetics are the easiest path to a successful federal trademark in this industry.
• Brands should use a mix of state-level trademarks and federal registrations for ancillary goods (like apparel) to build a protective wall around their name.